business

Provectus reports oral PV-10 bladder cancer study results

Investing.com · May 18, 2026, 12:13 PM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M Yahoo Finance Eli Lilly (LLY) Reports New Late-Stage Weight Loss Trial Results Yahoo Finance Clearway Energy (CWEN) Reports Mixed Q1 Results, Reaffirms 2026 Guidance Yahoo Finance Microchip Tech (MCHP) Reports Strong Q4 and FY 2026 Results, Exceeding EPS Guidance

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Provectus reports oral PV-10 bladder cancer study results

Also covered by

More in business